Gerry A Quinn

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Irritable Bowel Syndrome

Top Venues

Journal of clinical medicine

International journal of environmental research and public health

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Gerry A Quinn, Michael Connolly, Norman E Fenton, Steven J Hatfill, Paul D Hynds, Coilín ÓhAiseadha, Karol Sikora, Willie Soon, Ronan Connolly
Influence of Seasonality and Public-Health Interventions on the COVID-19 Pandemic in Northern Europe. Journal of clinical medicine 13 (2) (2024)
Gerry A Quinn, Michael Connolly, Norman E Fenton, Steven J Hatfill, Paul D Hynds, Coilín ÓhAiseadha, Karol Sikora, Willie Soon, Ronan Connolly
Influence of Seasonality and Public-Health Interventions on the COVID-19 Pandemic in Northern Europe. Journal of clinical medicine 13 (2) (2024)
Coilín ÓhAiseadha, Gerry A Quinn, Ronan Connolly, Awwad Wilson, Michael Connolly, Willie Soon, Paul D Hynds
Unintended Consequences of COVID-19 Non-Pharmaceutical Interventions (NPIs) for Population Health and Health Inequalities. International journal of environmental research and public health 20 (7) (2023)
Hamid A Bakshi, Gerry A Quinn, Mohamed M Nasef, Vijay Mishra, Alaa A A Aljabali, Mohamed El-Tanani, Ãngel Serrano-Aroca, Mateus Webba Da Silva, Paul A McCarron, Murtaza M Tambuwala
Crocin Inhibits Angiogenesis and Metastasis in Colon Cancer via TNF-α/NF-kB/VEGF Pathways. Cells 11 (9) (2022)
Ela Šarić, Gerry A Quinn, Nicolas Nalpas, Tina Paradžik, Saša Kazazić, Želimira Filić, Maja Šemanjski, Paul R Herron, Iain Hunter, Boris Maček, Dušica Vujaklija
Phosphoproteome Dynamics of Streptomyces rimosus during Submerged Growth and Antibiotic Production. mSystems 7 (5) (2022)
Hamid A Bakshi, Gerry A Quinn, Alaa A A Aljabali, Faruck L Hakkim, Rabia Farzand, Mohamed M Nasef, Naji Abuglela, Prawej Ansari, Vijay Mishra, Ãngel Serrano-Aroca, Murtaza M Tambuwala
Exploiting the Metabolism of the Gut Microbiome as a Vehicle for Targeted Drug Delivery to the Colon. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)